These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 29076065)

  • 1. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
    Shin B; Park W
    J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
    Tiwari V; Tiwari D; Patel V; Tiwari M
    Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
    Nowak P; Paluchowska P
    Folia Histochem Cytobiol; 2016; 54(2):61-74. PubMed ID: 27270503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
    Bonnin RA; Nordmann P; Poirel L
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):571-83. PubMed ID: 23750729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
    Kaliterna V; Kaliterna M; Hrenović J; Barišić Z; Tonkić M; Goic-Barisic I
    Infect Dis (Lond); 2015; 47(12):902-7. PubMed ID: 26365683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rice LB
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of
    Lee CR; Lee JH; Park M; Park KS; Bae IK; Kim YB; Cha CJ; Jeong BC; Lee SH
    Front Cell Infect Microbiol; 2017; 7():55. PubMed ID: 28348979
    [No Abstract]   [Full Text] [Related]  

  • 16. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of adjuvants in the treatment of Acinetobacter baumannii.
    Pachón-Ibáñez ME; Smani Y; Pachón J
    Expert Rev Anti Infect Ther; 2016; 14(2):153-5. PubMed ID: 26620637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.